...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: FDA

If the sub-group with Rosuvastatin has outstanding results, the FDA may approve a NDA. They have approved some that have missed the primary endpoint. Or maybe in Europe (EMA)? How about China? 

  

Share
New Message
Please login to post a reply